guanfacine has been researched along with Child Development Deviations in 2 studies
Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.
Excerpt | Relevance | Reference |
---|---|---|
"The present study involved a double-blind, placebo-controlled, crossover trial of guanfacine in 11 children (ages 5-9 years) with developmental disabilities and symptoms of inattention/overactivity." | 9.13 | Guanfacine in children with autism and/or intellectual disabilities. ( Handen, BL; Hardan, AY; Sahl, R, 2008) |
"The present study involved a double-blind, placebo-controlled, crossover trial of guanfacine in 11 children (ages 5-9 years) with developmental disabilities and symptoms of inattention/overactivity." | 5.13 | Guanfacine in children with autism and/or intellectual disabilities. ( Handen, BL; Hardan, AY; Sahl, R, 2008) |
"A 6-year-old boy referred for language delay and hyperactivity." | 2.66 | [ADCY5-associated dyskinesia in young children: a case report of a family and an updated review]. ( Aguilera-Nieto, L; Calvo-Medina, R; Ferrero-Turrión, J; Mora-Ramírez, MD; Ramos-Fernández, JM; Ruiz-García, C, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Aguilera-Nieto, L | 1 |
Ferrero-Turrión, J | 1 |
Mora-Ramírez, MD | 1 |
Calvo-Medina, R | 1 |
Ruiz-García, C | 1 |
Ramos-Fernández, JM | 1 |
Handen, BL | 1 |
Sahl, R | 1 |
Hardan, AY | 1 |
1 review available for guanfacine and Child Development Deviations
Article | Year |
---|---|
[ADCY5-associated dyskinesia in young children: a case report of a family and an updated review].
Topics: Adenylyl Cyclases; Amino Acid Substitution; Attention Deficit Disorder with Hyperactivity; Child; De | 2020 |
1 trial available for guanfacine and Child Development Deviations
Article | Year |
---|---|
Guanfacine in children with autism and/or intellectual disabilities.
Topics: Adrenergic alpha-Agonists; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; | 2008 |